M. Dehesa-davila and L. D. Possani, Scorpionism and serotherapy in Mexico, Toxicon, vol.32, issue.9, pp.1015-1018, 1994.
DOI : 10.1016/0041-0101(94)90383-2

M. Goyffon, M. Vachon, and N. Broglio, Epidemiological and clinical characteristics of the scorpion envenomation in Tunisia, Toxicon, vol.20, issue.1, pp.337-344, 1982.
DOI : 10.1016/0041-0101(82)90240-9

M. Bouaziz, M. Bahloul, H. Kallel, M. Samet, H. Ksibi et al., Epidemiological, clinical characteristics and outcome of severe scorpion envenomation in South Tunisia: Multivariate analysis of 951 cases, Toxicon, vol.52, issue.8, pp.918-926, 2008.
DOI : 10.1016/j.toxicon.2008.09.004

E. Jover, F. Couraud, and H. Rochat, Two types of scorpion neurotoxins characterized by their binding to two separate receptor sites on rat brain synaptosomes, Biochemical and Biophysical Research Communications, vol.95, issue.4, pp.1607-1614, 1980.
DOI : 10.1016/S0006-291X(80)80082-9

M. F. Martin-eauclaire and F. Couraud, Scorpions neurotoxins. Effects and Mechanisms, pp.683-716, 1995.

C. Devaux, B. Jouirou, M. Naceur-krifi, O. Clot-faybesse, M. Ayeb et al., Quantitative variability in the biodistribution and in toxinokinetic studies of the three main alpha toxins from the Androctonus australis hector scorpion venom, Toxicon, vol.43, issue.6, pp.661-669, 2004.
DOI : 10.1016/j.toxicon.2004.02.021

F. Miranda, C. Kopeyan, H. Rochat, and S. Lissitzky, Purification of Animal Neurotoxins. Isolation and Characterization of Eleven Neurotoxins from the Venoms of the Scorpions Androctonus australis Hector, Buthus occitanus tunetanus and Leiurus quinquestriatus quinquestriatus, European Journal of Biochemistry, vol.17, issue.3, pp.279-291, 1970.
DOI : 10.1016/0003-2697(60)90045-2

H. Rochat, P. Bernard, and F. Couraud, Scorpion toxins: chemistry and mode of action, Adv. Cytopharmacol, vol.3, pp.325-330, 1979.

J. C. Fontecilla-camps, C. Habersetzer-rochat, and H. Rochat, Orthorhombic crystals and three-dimensional structure of the potent toxin II from the scorpion Androctonus australis Hector., Proceedings of the National Academy of Sciences, vol.85, issue.20, pp.7443-7447, 1988.
DOI : 10.1073/pnas.85.20.7443

D. Housset, C. Haberstrer-rochat, J. P. Artier, and J. C. Fontecilla-camps, Crystal Structure of Toxin II from the Scorpion Androctonus australis Hector Refined at 1??3 ?? Resolution, Journal of Molecular Biology, vol.238, issue.1, pp.88-90, 1994.
DOI : 10.1006/jmbi.1994.1270

E. Ayeb, M. Martin, M. F. Delori, P. Bechis, G. Rochat et al., Immunochemistry of scorpion ?-neurotoxins. Determination of the antigenic site number and isolation of a highly enriched antibody specific to a single antigenic site of toxin II of Androctonus australis hector, Mol. Immunol, vol.20, pp.697-708, 1983.

E. Ayeb, M. Bahraoui, E. M. Granier, C. Rochat, and H. , Use of antibodies specific to defined regions of scorpion ?-toxin to study its interaction with its receptor sites on the sodium channel, Biochemistry, vol.139, pp.3371-3377, 1986.

C. Granier, J. Novotny, J. C. Fontecilla-camps, P. Fourquet, M. Ayeb et al., The antigenic structure of a scorpion toxin, Molecular Immunology, vol.26, issue.6, pp.503-513, 1989.
DOI : 10.1016/0161-5890(89)90001-1

J. P. Chippaux and M. Goyffon, Venoms, antivenoms and immunotherapy, Toxicon, vol.36, issue.6, pp.823-846, 1998.
DOI : 10.1016/S0041-0101(97)00160-8

S. Pepin-cavotta, C. Lutsch, M. Grandgeorge, J. Lang, and J. M. Scherrmann, Immunoreactivity and pharmacokinetics of horse anti-scorpion venom F(ab???)2-scorpion venom interactions, Toxicology and Applied Pharmacology, vol.141, issue.1, pp.272-277, 1996.
DOI : 10.1016/S0041-008X(96)80033-0

M. Ismail, The treatment of the scorpion envenoming syndrome: The Saudi experience with serotherapy, Toxicon, vol.32, issue.9, pp.1019-1026, 1994.
DOI : 10.1016/0041-0101(94)90384-0

F. Abroug, S. El-atrous, S. Nouira, H. Haguiga, . Touzi et al., Serotherapy in scorpion envenomation: a randomised controlled trial, The Lancet, vol.354, issue.9182, pp.906-909, 1999.
DOI : 10.1016/S0140-6736(98)12083-4

N. A. Rezende, C. F. Amaral, and L. Freire-maia, Immunotherapy for scorpion envenoming in Brazil, Toxicon, vol.36, issue.11, pp.1507-1513, 1998.
DOI : 10.1016/S0041-0101(98)00141-X

H. S. Bawaskar and P. H. Bawaskar, Utility of scorpion antivenin vs prazosin in the management of severe Mesobuthus tamulus envenoming at rural settings, J. Assoc. Physicians India, vol.55, pp.14-21, 2007.

S. Sofer, E. Shahak, and M. Gueron, Scorpion envenomation and antivenom therapy, The Journal of Pediatrics, vol.124, issue.6, pp.973-978, 1994.
DOI : 10.1016/S0022-3476(05)83196-8

E. Bahraoui, J. Pichon, J. M. Muller, H. Darbon, M. Ayeb et al., Monoclonal antobodies to scorpion toxins characterization and molecular mechanisms of neutralization, J. Immunol, vol.141, pp.214-220, 1988.

L. D. Possani and B. Becerril, A strategy for the generation of specific human antibodies by directed evolution and phage display. An example of a single-chain antibody fragment that neutralizes a major component of scorpion venom, FEBS J, vol.272, pp.2591-2601, 2005.

V. K. Nguyen, A. Desmyter, and S. Muyldermans, Functional heavy-chain antibodies in camelidae, Adv. Immunol, vol.79, pp.261-296, 2001.
DOI : 10.1016/S0065-2776(01)79006-2

V. Cortez-retamozo, N. Backmann, P. D. Senter, U. Wernery, P. De-baetselier et al., Efficient Cancer Therapy with a Nanobody-Based Conjugate, Cancer Research, vol.64, issue.8, pp.1256-1261, 2004.
DOI : 10.1158/0008-5472.CAN-03-3935

D. Saerens, F. Frederix, G. Reekmans, K. Conrath, K. Jans et al., Engineering Camel Single-Domain Antibodies and Immobilization Chemistry for Human Prostate-Specific Antigen Sensing, Analytical Chemistry, vol.77, issue.23, pp.7547-7555, 2005.
DOI : 10.1021/ac051092j

T. N. Baral, S. Magez, B. Stijlemans, K. Conrath, B. Vanhollebeke et al., Experimental therapy of African trypanosomiasis with a nanobody-conjugated human trypanolytic factor, Nature Medicine, vol.350, issue.5, pp.914-916, 2006.
DOI : 10.1038/nm1395

S. Muyldermans, T. Atarhouch, J. Saldanha, J. A. Barbosa, and R. Hamers, domain from naturally occurring camel heavy chain immunoglobulins lacking light chains, "Protein Engineering, Design and Selection", vol.7, issue.9, pp.1129-1135, 1994.
DOI : 10.1093/protein/7.9.1129

F. Meddeb-mouelhi, B. Bouhaouala-zahar, Z. Benlasfar, M. Hammadi, T. Mejri et al., Immunized camel sera and derived immunoglobulin subclasses neutralizing Androctonus australis hector scorpion toxins, Toxicon, vol.42, issue.7, pp.785-791, 2003.
DOI : 10.1016/j.toxicon.2003.10.021

M. Arbabi-ghahroudi, A. Desmyter, L. Wyns, R. Hamers, and S. Muyldermans, Selection and identification of single domain antibody fragments from camel heavy-chain antibodies, FEBS Letters, vol.15, issue.3, pp.521-526, 1997.
DOI : 10.1016/S0014-5793(97)01062-4

K. E. Conrath, M. Lauwereys, M. Galleni, A. Matagne, J. Frère et al., ??-Lactamase Inhibitors Derived from Single-Domain Antibody Fragments Elicited in the Camelidae, Antimicrobial Agents and Chemotherapy, vol.45, issue.10, pp.2807-2812, 2001.
DOI : 10.1128/AAC.45.10.2807-2812.2001

B. Bouhaouala-zahar, F. Ducancel, I. Zenouaki, B. Khalifa, R. Borchani et al., A Recombinant Insect-Specific alpha-Toxin of Buthus occitanus tunetanus Scorpion Confers Protection Against Homologous Mammal Toxins, European Journal of Biochemistry, vol.30, issue.3, pp.653-660, 1996.
DOI : 10.1016/0041-0101(71)90038-9
URL : https://hal.archives-ouvertes.fr/pasteur-00878681

I. Hmila, B. Abderrazek-ben-abdallah, R. Saerens, D. Benlasfar, Z. Conrath et al., VHH, bivalent domains and chimeric Heavy chain-only antibodies with high neutralizing efficacy for scorpion toxin AahI???, Molecular Immunology, vol.45, issue.14, pp.3847-3856, 2008.
DOI : 10.1016/j.molimm.2008.04.011
URL : https://hal.archives-ouvertes.fr/pasteur-01375223

M. P. Lefranc, C. Pommie, M. Ruiz, V. Giudicelli, E. Foulquier et al., IMGT unique numbering for immunoglobulin and T cell receptor variable domains and Ig superfamily V-like domains, Developmental & Comparative Immunology, vol.27, issue.1, pp.55-77, 2003.
DOI : 10.1016/S0145-305X(02)00039-3

D. Genst, E. Silence, K. Ghahroudi, M. A. Decanniere, K. Loris et al., Strong in Vivo Maturation Compensates for Structurally Restricted H3 Loops in Antibody Repertoires, Journal of Biological Chemistry, vol.280, issue.14, pp.14114-14121, 2005.
DOI : 10.1074/jbc.M413011200

D. Genst, E. Silence, K. Decanniere, K. Conrath, K. Loris et al., Molecular basis for the preferential cleft recognition by dromedary heavy-chain antibodies, Proceedings of the National Academy of Sciences, vol.103, issue.12, pp.4586-4591, 2006.
DOI : 10.1073/pnas.0505379103

J. C. Boulain, A. Ménez, J. Couderc, G. Faure, P. Liacopoulos et al., Neutralizing monoclonal antibody specific for Naja nigricollis toxin .alpha.: preparation, characterization and localization of the antigenic binding site, Biochemistry, vol.21, issue.12, pp.2910-2915, 1982.
DOI : 10.1021/bi00541a016

J. M. Grognet, E. Gatineau, P. Bougis, A. L. Harvey, J. Couderc et al., Two neutralizing monoclonal antibodies specific for Naja nigricollis cardiotoxin: Preparation, characterization and localization of the epitopes, Molecular Immunology, vol.23, issue.12, pp.1329-1337, 1986.
DOI : 10.1016/0161-5890(86)90018-0

V. R. Juarez-gonzalez, L. Riano-umbariala, V. Quintero-hernandez, T. Olamendi-portugal, M. Ortiz-leon et al., Directed Evolution, Phage Display and Combination of Evolved Mutants: A Strategy to Recover the Neutralization Properties of the scFv Version of BCF2 a Neutralizing Monoclonal Antibody Specific to Scorpion Toxin Cn2, Journal of Molecular Biology, vol.346, issue.5, pp.1287-1297, 2005.
DOI : 10.1016/j.jmb.2004.12.060

V. Quintero-hernández, V. R. Juárez-gonzález, M. Ortíz-león, R. Sánchez, L. D. Possani et al., The change of the scFv into the Fab format improves the stability and in vivo toxin neutralization capacity of recombinant antibodies, Molecular Immunology, vol.44, issue.6, pp.1307-1315, 2007.
DOI : 10.1016/j.molimm.2006.05.009

S. Muyldermans, Single domain camel antibodies: current status, Reviews in Molecular Biotechnology, vol.74, issue.4, pp.277-302, 2001.
DOI : 10.1016/S1389-0352(01)00021-6

L. G. Frenken, R. H. Van-der-linden, P. W. Hermans, J. W. Bos, R. C. Ruuls et al., Isolation of antigen specific Llama V HH antibody fragments and their high level secretion by Saccharomyces cerevisiae, 2000.

C. Vincke, R. Loris, D. Saerens, S. Martinez-rodriguez, S. Muyldermans et al., General Strategy to Humanize a Camelid Single-domain Antibody and Identification of a Universal Humanized Nanobody Scaffold, Journal of Biological Chemistry, vol.284, issue.5, pp.3273-3284, 2009.
DOI : 10.1074/jbc.M806889200